Author Archive: Jim Greenwood

Jim Greenwood

Jim joined BIO as President & CEO in 2005 after representing the eighth district of Pennsylvania in the U.S. House of Representatives for six terms.  He had worked with BIO while in Congress on stem cell research and other health issues, and has since learned so much about the many applications of the science in food and agriculture and in industrial and environmental biotechnology.

Due to its revolutionary research and development in issues ranging from feeding the world by increasing crop yields to healing the world with new medicines to providing cleaner sources of energy, Jim is a passionate champion for biotechnology. When visiting member companies, he is inspired by executives and scientists who are united in their mission to help patients, farmers and other consumers lead a better life.

Prior to Congress, Jim served in the Pennsylvania House of Representatives and Pennsylvania Senate for six years each.  He and his wife Tina live in historic Washington Crossing, Pennsylvania (where he has participated in the re-enactment of George Washington crossing the Delaware River on Christmas Day in 1776). He enjoys fishing, birding and scuba diving.

You can find him on Facebook at https://www.facebook.com/jamescgreenwood.

Latest Posts

A Call to Arms for Renewable Fuels

Jim Greenwood

BIO President & CEO Jim Greenwood delivered remarks on the Renewable Fuel Standard and participated in a panel session on the Legacy of Bipartisan Support for Renewable Energy at ACORE’s National Renewable Energy Policy Forum, held on Capitol Hill: Good afternoon. It is good to be with ACORE again and to be part of your 10th annual policy forum. I had the pleasure of speaking at the RETECH 2012 conference in October. I said then Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

Jim Greenwood

I was recently asked what the single biggest threat to the biotechnology industry is today.  My answer was immediate – the biggest threat to biotech innovation is the unsustainable mismatch of spending and revenue in the U.S. federal budget. The enormous national debt and the huge annual budget deficits that feed it endanger America’s entire economic future – but the nation’s dire fiscal situation is particularly threatening to our industry. Part of the reason for Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,

The Presidential Inaugural: BIO Stands Ready to work with President Obama

Jim Greenwood

Today we congratulate President Obama on his swearing-in as President of the United States. BIO looks forward to continuing to work with the president and his administration over the next four years to craft policies that will help create jobs, propel continued innovation, and increase our nation’s competitiveness in the global marketplace. The United States remains the world leader in biotechnology. Our nation’s biotechnology industry is comprised of scientists, entrepreneurs and large and small companies Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

How the Biotechnology Industry Can Combat Doping in Sports

Track

Biotechnology companies work every day to solve some of our biggest global challenges – fighting disease, hunger and pollution. Yet, we in the biotech industry are strongly aware that our products can also be misused in the wrong hands. The same medicines that can be used to help children with devastating genetic deficiencies and growth disorders, or to help a chemotherapy patient combat cancer, can also be abused by healthy athletes to gain an unfair Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , , ,

New Drug Disposal Law Doesn’t Make Sense

rxpills-btn

Product stewardship is a broad term applied across many industries, encompassing environmental, health, and safety concerns. Companies in each sector of the biotech industry (healthcare, agricultural, and industrial and environmental) have championed stewardship programs for many years – not just because it makes good business sense, but because they believe it is the right thing to do. Within the healthcare space, the impact of pharmaceuticals in the environment has become an issue of emerging debate. Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: ,